• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB

DIMERIX LIMITED - Announcements

1.05% ! 47.0¢
Market Cap $282.0M  !

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

Announcements



DXB Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE30/10/23 download Created with Sketch. 669.16KB
DXB Notification of cessation of securities - DXB25/10/23 download Created with Sketch. 21.71KB
DXB Letter to Shareholders, Notice of AGM & Proxy Form24/10/23 download Created with Sketch. 896.39KB
DXB Dimerix Appoints Chief Medical Officer23/10/23 download Created with Sketch. 337.98KB
DXB Application for quotation of securities - DXB20/10/23 download Created with Sketch. 24.93KB
DXB Application for quotation of securities - DXB17/10/23 download Created with Sketch. 24.92KB
DXB Application for quotation of securities - DXB16/10/23 download Created with Sketch. 24.88KB
DXB Application for quotation of securities - DXB09/10/23 download Created with Sketch. 24.88KB
DXB Investor Webinar and Presentation05/10/23 download Created with Sketch. 2.11MB
DXB Dimerix Announces License Agreement for EU, Canada, ANZPRICE SENSITIVE05/10/23 download Created with Sketch. 349.93KB
DXB Trading HaltPRICE SENSITIVE04/10/23 download Created with Sketch. 428.4KB
DXB Notification of Date of 2023 AGM25/09/23 download Created with Sketch. 290.43KB
DXB FDA Approves Qytovra Brand NamePRICE SENSITIVE25/09/23 download Created with Sketch. 438.29KB
DXB Regulatory Approval received in Malaysia for ACTION3 StudyPRICE SENSITIVE22/09/23 download Created with Sketch. 409.35KB
DXB Application for quotation of securities - DXB19/09/23 download Created with Sketch. 24.88KB
DXB Dimerix Receives $8.9M R&D Tax Incentive RebatePRICE SENSITIVE13/09/23 download Created with Sketch. 369.5KB
DXB Appendix 4G and Corporate Governance Statement30/08/23 download Created with Sketch. 491KB
DXB Annual Report30/08/23 download Created with Sketch. 2.49MB
DXB Preliminary Final ReportPRICE SENSITIVE30/08/23 download Created with Sketch. 305.86KB
DXB Notification regarding unquoted securities - DXB28/08/23 download Created with Sketch. 23.72KB
DXB Application for quotation of securities - DXB28/08/23 download Created with Sketch. 26.82KB
DXB Notification regarding unquoted securities - DXB09/08/23 download Created with Sketch. 23.77KB
DXB Application for quotation of securities - DXB09/08/23 download Created with Sketch. 26.95KB
DXB Successful Completion of 2nd DSMB Review of FSGS TrialPRICE SENSITIVE08/08/23 download Created with Sketch. 371.69KB
DXB Investor Presentation01/08/23 download Created with Sketch. 4.13MB
DXB Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE28/07/23 download Created with Sketch. 646.25KB
DXB Dimerix presentation at Bioshares Biotech Summit24/07/23 download Created with Sketch. 2.54MB
DXB DMX-200 FSGS PH3 Kidney Trial Part 1 Outcome set for Q1 CY24PRICE SENSITIVE24/07/23 download Created with Sketch. 397KB
DXB Approval received for Paediatric Investigation Plan from EMAPRICE SENSITIVE05/07/23 download Created with Sketch. 340.9KB
DXB Change of Director's Interest Notices - NW and SP04/07/23 download Created with Sketch. 280.95KB
DXB Dimerix confirms Phase 3 study design appropriate for ChinaPRICE SENSITIVE03/07/23 download Created with Sketch. 369.74KB
DXB Application for quotation of securities - DXB29/06/23 download Created with Sketch. 26.89KB
DXB Application for quotation of securities - DXB29/06/23 download Created with Sketch. 24.9KB
DXB Application for quotation of securities - DXB29/06/23 download Created with Sketch. 24.94KB
DXB Application for quotation of securities - DXB29/06/23 download Created with Sketch. 24.95KB
DXB Notification regarding unquoted securities - DXB29/06/23 download Created with Sketch. 23.6KB
DXB Notification regarding unquoted securities - DXB29/06/23 download Created with Sketch. 23.77KB
DXB ProspectusPRICE SENSITIVE26/06/23 download Created with Sketch. 629.37KB
DXB Results of Meeting20/06/23 download Created with Sketch. 492.44KB
DXB Application for quotation of securities - DXB15/06/23 download Created with Sketch. 25.08KB
DXB Change of Director's Interest Notices - NW and SP13/06/23 download Created with Sketch. 281.44KB
DXB Change in substantial holding06/06/23 download Created with Sketch. 136.6KB
DXB Dimerix to present at BIO International Convention06/06/23 download Created with Sketch. 3.24MB
DXB Top 20 Option Holders & Distribution Schedule05/06/23 download Created with Sketch. 83.23KB
DXB Notification regarding unquoted securities - DXB05/06/23 download Created with Sketch. 23.76KB
DXB Application for quotation of securities - DXB05/06/23 download Created with Sketch. 26.98KB
DXB Dimerix Announces Update on Successful Capital RaisePRICE SENSITIVE05/06/23 download Created with Sketch. 333.7KB
DXB Reminder of Closing Date for Non-Renounceable Rights Offer26/05/23 download Created with Sketch. 328.35KB
DXB Application for quotation of securities - DXB25/05/23 download Created with Sketch. 24.76KB
DXB Notification regarding unquoted securities - DXB25/05/23 download Created with Sketch. 28.25KB
DXB Letter to Shareholders, Notice of Meeting & Proxy Form22/05/23 download Created with Sketch. 951.32KB
DXB Letter to Ineligible Foreign Shareholders12/05/23 download Created with Sketch. 292.88KB
DXB Letter to Nominees and Custodians12/05/23 download Created with Sketch. 333.52KB
DXB Despatch of Prospectus and Letter to Eligible Shareholders12/05/23 download Created with Sketch. 1.31MB
DXB Investor Webinar04/05/23 download Created with Sketch. 285.53KB
DXB Rights Issue ProspectusPRICE SENSITIVE04/05/23 download Created with Sketch. 867.89KB
DXB Reinstatement to Official QuotationPRICE SENSITIVE04/05/23 download Created with Sketch. 86.04KB
DXB Investor Presentation04/05/23 download Created with Sketch. 5.87MB
DXB Proposed issue of securities - DXB04/05/23 download Created with Sketch. 24.61KB
DXB Proposed issue of securities - DXB04/05/23 download Created with Sketch. 40.12KB
DXB Proposed issue of securities - DXB04/05/23 download Created with Sketch. 26.92KB
DXB Proposed issue of securities - DXB04/05/23 download Created with Sketch. 27.42KB
DXB Proposed issue of securities - DXB04/05/23 download Created with Sketch. 31.09KB
DXB Proposed issue of securities - DXB04/05/23 download Created with Sketch. 27.35KB
DXB Entitlement offer and Convertible Note to raise $12 millionPRICE SENSITIVE04/05/23 download Created with Sketch. 400.75KB
DXB Voluntary SuspensionPRICE SENSITIVE03/05/23 download Created with Sketch. 427.13KB
DXB Initial Director's Interest Notice - CS02/05/23 download Created with Sketch. 248.77KB
DXB Dimerix Announces New Board Member01/05/23 download Created with Sketch. 280.66KB
DXB Trading HaltPRICE SENSITIVE01/05/23 download Created with Sketch. 441.08KB
DXB Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE28/04/23 download Created with Sketch. 575KB
DXB Ceasing to be a substantial holder21/04/23 download Created with Sketch. 177.56KB
DXB FSGS Study, Partnering & Commercialisation Investor Briefing22/03/23 download Created with Sketch. 2.05MB
DXB Half-Year Financial Report & Appendix 4D - 31 December 2022PRICE SENSITIVE27/02/23 download Created with Sketch. 946.74KB
DXB DXB to Receive $2.8m in Prepayment of R&D Tax IncentivePRICE SENSITIVE17/02/23 download Created with Sketch. 349.24KB
DXB Successful Completion of DSMB Review of Phase 3 FSGS TrialPRICE SENSITIVE09/02/23 download Created with Sketch. 339.4KB
DXB Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE31/01/23 download Created with Sketch. 663.86KB
DXB FDA Confirms Inclusion of Paediatrics in ACTION3 StudyPRICE SENSITIVE12/01/23 download Created with Sketch. 348.11KB
DXB Final Director's Interest Notice28/12/22 download Created with Sketch. 3.47KB
DXB Resignation of Non-Executive Chairman23/12/22 download Created with Sketch. 302.82KB
DXB DMX-200 FSGS Phase 3 Trial Part 1 Recruitment AchievedPRICE SENSITIVE15/12/22 download Created with Sketch. 346.26KB
DXB CLARITY 2.0 COVID-19 Study OutcomePRICE SENSITIVE13/12/22 download Created with Sketch. 268.03KB
DXB Constitution29/11/22 download Created with Sketch. 934.32KB
DXB Results of Meeting29/11/22 download Created with Sketch. 282.89KB
DXB Chair address and CEO presentation to AGMPRICE SENSITIVE29/11/22 download Created with Sketch. 2.72MB
DXB Investor Briefing23/11/22 download Created with Sketch. 3.61MB
DXB Letter to Shareholders, Notice of AGM & Proxy Form27/10/22 download Created with Sketch. 952.33KB
DXB AusBioInvest Presentation, including FSGS recruitment update27/10/22 download Created with Sketch. 2.96MB
DXB Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE27/10/22 download Created with Sketch. 522.62KB
DXB Dimerix Receives A$6.0M R&D Tax Incentive RebatePRICE SENSITIVE25/10/22 download Created with Sketch. 322.4KB
DXB Notification of Date of 2022 AGM04/10/22 download Created with Sketch. 287.34KB
DXB Investor Presentation15/09/22 download Created with Sketch. 6.98MB
DXB Appendix 4G and Corporate Governance Statement29/08/22 download Created with Sketch. 542.66KB
DXB Appendix 4E and 2022 Annual ReportPRICE SENSITIVE29/08/22 download Created with Sketch. 1.86MB
DXB CLARITY 2.0 COVID-19 Study Concludes RecruitmentPRICE SENSITIVE18/08/22 download Created with Sketch. 260.33KB
DXB Notification of cessation of securities - DXB10/08/22 download Created with Sketch. 21.51KB
DXB New Patent Family Application for DMX-700PRICE SENSITIVE09/08/22 download Created with Sketch. 267.59KB
DXB Quarterly Appendix 4C and Activities ReportPRICE SENSITIVE27/07/22 download Created with Sketch. 539.64KB
DXB Notification regarding unquoted securities - DXB25/07/22 download Created with Sketch. 25.22KB
DXB DMX-700 Study Shows Significant 80% Reduction in Lung InjuryPRICE SENSITIVE04/07/22 download Created with Sketch. 358.13KB
DXB REMAP-CAP COVID-19 Study Analysis UpdatePRICE SENSITIVE27/06/22 download Created with Sketch. 257.28KB
DXB Quarterly Appendix 4C and Activities Report
30/10/23PRICE SENSITIVE download Created with Sketch. 669.16KB
DXB Notification of cessation of securities - DXB
25/10/23 download Created with Sketch. 21.71KB
DXB Letter to Shareholders, Notice of AGM & Proxy Form
24/10/23 download Created with Sketch. 896.39KB
DXB Dimerix Appoints Chief Medical Officer
23/10/23 download Created with Sketch. 337.98KB
DXB Application for quotation of securities - DXB
20/10/23 download Created with Sketch. 24.93KB
DXB Application for quotation of securities - DXB
17/10/23 download Created with Sketch. 24.92KB
DXB Application for quotation of securities - DXB
16/10/23 download Created with Sketch. 24.88KB
DXB Application for quotation of securities - DXB
09/10/23 download Created with Sketch. 24.88KB
DXB Investor Webinar and Presentation
05/10/23 download Created with Sketch. 2.11MB
DXB Dimerix Announces License Agreement for EU, Canada, ANZ
05/10/23PRICE SENSITIVE download Created with Sketch. 349.93KB
DXB Trading Halt
04/10/23PRICE SENSITIVE download Created with Sketch. 428.4KB
DXB Notification of Date of 2023 AGM
25/09/23 download Created with Sketch. 290.43KB
DXB FDA Approves Qytovra Brand Name
25/09/23PRICE SENSITIVE download Created with Sketch. 438.29KB
DXB Regulatory Approval received in Malaysia for ACTION3 Study
22/09/23PRICE SENSITIVE download Created with Sketch. 409.35KB
DXB Application for quotation of securities - DXB
19/09/23 download Created with Sketch. 24.88KB
DXB Dimerix Receives $8.9M R&D Tax Incentive Rebate
13/09/23PRICE SENSITIVE download Created with Sketch. 369.5KB
DXB Appendix 4G and Corporate Governance Statement
30/08/23 download Created with Sketch. 491KB
DXB Annual Report
30/08/23 download Created with Sketch. 2.49MB
DXB Preliminary Final Report
30/08/23PRICE SENSITIVE download Created with Sketch. 305.86KB
DXB Notification regarding unquoted securities - DXB
28/08/23 download Created with Sketch. 23.72KB
DXB Application for quotation of securities - DXB
28/08/23 download Created with Sketch. 26.82KB
DXB Notification regarding unquoted securities - DXB
09/08/23 download Created with Sketch. 23.77KB
DXB Application for quotation of securities - DXB
09/08/23 download Created with Sketch. 26.95KB
DXB Successful Completion of 2nd DSMB Review of FSGS Trial
08/08/23PRICE SENSITIVE download Created with Sketch. 371.69KB
DXB Investor Presentation
01/08/23 download Created with Sketch. 4.13MB
DXB Quarterly Appendix 4C and Activities Report
28/07/23PRICE SENSITIVE download Created with Sketch. 646.25KB
DXB Dimerix presentation at Bioshares Biotech Summit
24/07/23 download Created with Sketch. 2.54MB
DXB DMX-200 FSGS PH3 Kidney Trial Part 1 Outcome set for Q1 CY24
24/07/23PRICE SENSITIVE download Created with Sketch. 397KB
DXB Approval received for Paediatric Investigation Plan from EMA
05/07/23PRICE SENSITIVE download Created with Sketch. 340.9KB
DXB Change of Director's Interest Notices - NW and SP
04/07/23 download Created with Sketch. 280.95KB
DXB Dimerix confirms Phase 3 study design appropriate for China
03/07/23PRICE SENSITIVE download Created with Sketch. 369.74KB
DXB Application for quotation of securities - DXB
29/06/23 download Created with Sketch. 26.89KB
DXB Application for quotation of securities - DXB
29/06/23 download Created with Sketch. 24.9KB
DXB Application for quotation of securities - DXB
29/06/23 download Created with Sketch. 24.94KB
DXB Application for quotation of securities - DXB
29/06/23 download Created with Sketch. 24.95KB
DXB Notification regarding unquoted securities - DXB
29/06/23 download Created with Sketch. 23.6KB
DXB Notification regarding unquoted securities - DXB
29/06/23 download Created with Sketch. 23.77KB
DXB Prospectus
26/06/23PRICE SENSITIVE download Created with Sketch. 629.37KB
DXB Results of Meeting
20/06/23 download Created with Sketch. 492.44KB
DXB Application for quotation of securities - DXB
15/06/23 download Created with Sketch. 25.08KB
DXB Change of Director's Interest Notices - NW and SP
13/06/23 download Created with Sketch. 281.44KB
DXB Change in substantial holding
06/06/23 download Created with Sketch. 136.6KB
DXB Dimerix to present at BIO International Convention
06/06/23 download Created with Sketch. 3.24MB
DXB Top 20 Option Holders & Distribution Schedule
05/06/23 download Created with Sketch. 83.23KB
DXB Notification regarding unquoted securities - DXB
05/06/23 download Created with Sketch. 23.76KB
DXB Application for quotation of securities - DXB
05/06/23 download Created with Sketch. 26.98KB
DXB Dimerix Announces Update on Successful Capital Raise
05/06/23PRICE SENSITIVE download Created with Sketch. 333.7KB
DXB Reminder of Closing Date for Non-Renounceable Rights Offer
26/05/23 download Created with Sketch. 328.35KB
DXB Application for quotation of securities - DXB
25/05/23 download Created with Sketch. 24.76KB
DXB Notification regarding unquoted securities - DXB
25/05/23 download Created with Sketch. 28.25KB
DXB Letter to Shareholders, Notice of Meeting & Proxy Form
22/05/23 download Created with Sketch. 951.32KB
DXB Letter to Ineligible Foreign Shareholders
12/05/23 download Created with Sketch. 292.88KB
DXB Letter to Nominees and Custodians
12/05/23 download Created with Sketch. 333.52KB
DXB Despatch of Prospectus and Letter to Eligible Shareholders
12/05/23 download Created with Sketch. 1.31MB
DXB Investor Webinar
04/05/23 download Created with Sketch. 285.53KB
DXB Rights Issue Prospectus
04/05/23PRICE SENSITIVE download Created with Sketch. 867.89KB
DXB Reinstatement to Official Quotation
04/05/23PRICE SENSITIVE download Created with Sketch. 86.04KB
DXB Investor Presentation
04/05/23 download Created with Sketch. 5.87MB
DXB Proposed issue of securities - DXB
04/05/23 download Created with Sketch. 24.61KB
DXB Proposed issue of securities - DXB
04/05/23 download Created with Sketch. 40.12KB
DXB Proposed issue of securities - DXB
04/05/23 download Created with Sketch. 26.92KB
DXB Proposed issue of securities - DXB
04/05/23 download Created with Sketch. 27.42KB
DXB Proposed issue of securities - DXB
04/05/23 download Created with Sketch. 31.09KB
DXB Proposed issue of securities - DXB
04/05/23 download Created with Sketch. 27.35KB
DXB Entitlement offer and Convertible Note to raise $12 million
04/05/23PRICE SENSITIVE download Created with Sketch. 400.75KB
DXB Voluntary Suspension
03/05/23PRICE SENSITIVE download Created with Sketch. 427.13KB
DXB Initial Director's Interest Notice - CS
02/05/23 download Created with Sketch. 248.77KB
DXB Dimerix Announces New Board Member
01/05/23 download Created with Sketch. 280.66KB
DXB Trading Halt
01/05/23PRICE SENSITIVE download Created with Sketch. 441.08KB
DXB Quarterly Appendix 4C and Activities Report
28/04/23PRICE SENSITIVE download Created with Sketch. 575KB
DXB Ceasing to be a substantial holder
21/04/23 download Created with Sketch. 177.56KB
DXB FSGS Study, Partnering & Commercialisation Investor Briefing
22/03/23 download Created with Sketch. 2.05MB
DXB Half-Year Financial Report & Appendix 4D - 31 December 2022
27/02/23PRICE SENSITIVE download Created with Sketch. 946.74KB
DXB DXB to Receive $2.8m in Prepayment of R&D Tax Incentive
17/02/23PRICE SENSITIVE download Created with Sketch. 349.24KB
DXB Successful Completion of DSMB Review of Phase 3 FSGS Trial
09/02/23PRICE SENSITIVE download Created with Sketch. 339.4KB
DXB Quarterly Appendix 4C and Activities Report
31/01/23PRICE SENSITIVE download Created with Sketch. 663.86KB
DXB FDA Confirms Inclusion of Paediatrics in ACTION3 Study
12/01/23PRICE SENSITIVE download Created with Sketch. 348.11KB
DXB Final Director's Interest Notice
28/12/22 download Created with Sketch. 3.47KB
DXB Resignation of Non-Executive Chairman
23/12/22 download Created with Sketch. 302.82KB
DXB DMX-200 FSGS Phase 3 Trial Part 1 Recruitment Achieved
15/12/22PRICE SENSITIVE download Created with Sketch. 346.26KB
DXB CLARITY 2.0 COVID-19 Study Outcome
13/12/22PRICE SENSITIVE download Created with Sketch. 268.03KB
DXB Constitution
29/11/22 download Created with Sketch. 934.32KB
DXB Results of Meeting
29/11/22 download Created with Sketch. 282.89KB
DXB Chair address and CEO presentation to AGM
29/11/22PRICE SENSITIVE download Created with Sketch. 2.72MB
DXB Investor Briefing
23/11/22 download Created with Sketch. 3.61MB
DXB Letter to Shareholders, Notice of AGM & Proxy Form
27/10/22 download Created with Sketch. 952.33KB
DXB AusBioInvest Presentation, including FSGS recruitment update
27/10/22 download Created with Sketch. 2.96MB
DXB Quarterly Appendix 4C and Activities Report
27/10/22PRICE SENSITIVE download Created with Sketch. 522.62KB
DXB Dimerix Receives A$6.0M R&D Tax Incentive Rebate
25/10/22PRICE SENSITIVE download Created with Sketch. 322.4KB
DXB Notification of Date of 2022 AGM
04/10/22 download Created with Sketch. 287.34KB
DXB Investor Presentation
15/09/22 download Created with Sketch. 6.98MB
DXB Appendix 4G and Corporate Governance Statement
29/08/22 download Created with Sketch. 542.66KB
DXB Appendix 4E and 2022 Annual Report
29/08/22PRICE SENSITIVE download Created with Sketch. 1.86MB
DXB CLARITY 2.0 COVID-19 Study Concludes Recruitment
18/08/22PRICE SENSITIVE download Created with Sketch. 260.33KB
DXB Notification of cessation of securities - DXB
10/08/22 download Created with Sketch. 21.51KB
DXB New Patent Family Application for DMX-700
09/08/22PRICE SENSITIVE download Created with Sketch. 267.59KB
DXB Quarterly Appendix 4C and Activities Report
27/07/22PRICE SENSITIVE download Created with Sketch. 539.64KB
DXB Notification regarding unquoted securities - DXB
25/07/22 download Created with Sketch. 25.22KB
DXB DMX-700 Study Shows Significant 80% Reduction in Lung Injury
04/07/22PRICE SENSITIVE download Created with Sketch. 358.13KB
DXB REMAP-CAP COVID-19 Study Analysis Update
27/06/22PRICE SENSITIVE download Created with Sketch. 257.28KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
47.0¢
Change
-0.005(1.05%)
Mkt cap ! $282.0M
Open High Low Value Volume
47.0¢ 49.3¢ 46.5¢ $1.188M 2.509M

Buyers (Bids)

No. Vol. Price($)
3 28330 47.0¢
 

Sellers (Offers)

Price($) Vol. No.
49.0¢ 48233 4
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
Last
47.0¢
  Change
-0.005 ( 1.67 %)
Open High Low Volume
47.0¢ 48.5¢ 46.5¢ 960457
Last updated 15.55pm 31/07/2025 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.